Acute psychosis followed by fever – Malignant neuroleptic syndrome or viral encephalitis?

  • Zvezdana Stojanović Clinic of Psychiatry, Military Medical Academy, Belgrade Serbia
  • Željko Špirić Clinic of Psychiatry, Military Medical Academy, Belgrade Serbia; Faculty of Medicine of the Military Medical Academy, University of Defence, Belgrade, Serbia
Keywords: neuroleptic malignant syndrome, encephalitis, viral, diagnosis, differential, treatment outcome,

Abstract


 

Introduction. Neuroleptic malignant syndrome is rare, but potentially fatal idiosyncratic reaction to antipsychotic medications. It is sometimes difficult to diagnose some clinical cases as neuroleptic malignant syndrome and differentiate it from the acute viral encephalitis. Case report. We reported a patient diagnosed with acute psychotic reaction which appeared for the first time. The treatment started with typical antipsychotic, which led to febrility. The clinical presentation of the patient was characterised by the signs and symptoms that might have indicated the neuroleptic malignant syndrome as well as central nervous system viral disease. In order to make a detailed diagnosis additional procedures were performed: electroencephalogram, magnetic resonance imaging of the head, lumbar puncture and a serological test of the cerebrospinal fluid. Considering that after the tests viral encephalitis was ruled out and the diagnosis of neuroleptic malignant syndrome made, antipsychotic therapy was immediately stopped. The patient was initially treated with symptomatic therapy and after that with atypical antipsychotic and electroconvulsive therapy, which led to complete recovery. Conclusion. We present the difficulties of early diagnosis at the first episode of acute psychotic disorder associated with acute febrile condition. Concerning the differential diagnosis it is necessary to consider both neuroleptic malignant syndrome and viral encephalitis, i.e. it is necessary to make the neuroradiological diagnosis and conduct cerebrospinal fluid analysis and blood test. In neuroleptic malignant syndrome treatment a combined use of electroconvulsive therapy and low doses of atypical antipsychotic are confirmed to be successful.

Author Biography

Zvezdana Stojanović, Clinic of Psychiatry, Military Medical Academy, Belgrade Serbia
Clinic of psychiatry

References

Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatr Serv 1998; 49(9): 1163−72.

Geethan J, Chandran GJ, Mikler JR, Keegan DL. Neuroleptic ma-lignant syndrome: case report and discussion. Can Med Assoc J 2003; 169(5): 439−42.

Caroff SN, Mann SC, McCarthy M, Naser J, Rynn M, Morrison M. Acute infectious encephalitis complicated by neuroleptic ma-lignant syndrome. J Clin Psychopharmacol 1998; 18(4): 349−51.

Hillis RE, Lee DA. Viral encephalitis complicated by neurolep-tic malignant syndrome in a 7-year-old girl. Pediatr Emerg Care 2003; 19(2): 99−100.

Mihara K, Kondo T, Suzuki A. Relationship between functional dopamine D2 and D3 receptors gene polymorphisms and neuroleptic malignant syndrome. Am J Med Genet B Neuropsychiatr Genet 2003; 117B(1): 57−60.

Bourgeois JA, Babine S, Meyerovich M, Doyle JA. A Case of Neuro-leptic Malignant Syndrome With Quetiapine. J Neuropsychia-try Clin Neurosci 2002; 14(1): 87.

Adnet P, Lestavel P, Krivosic-Horber R. Neuroleptic malignant syndrome. Br J Anaesth 2000; 85(1): 129−35.

Stevens JR, Livermore A. Telemetered EEG in schizophrenia: spectral analysis during abnormal behaviour episodes. J Neurol Neurosurg Psychiatry 1982; 45(5): 385−95.

Gattaz WF, Mayer S, Ziegler P, Platz M, Gasser T. Hypofrontality on topographic EEG in schizophrenia. Correlations with neu-ropsychological and psychopathological parameters. Eur Arch Psychiatry Clin Neurosci 1992; 241(6): 328−32.

Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2005; 12(5): 331−43.

Chaudhuri A, Kennedy PG. Diagnosis and treatment of viral en-cephalitis. Postgrad Med J 2002; 78(924): 575−83.

Hermesh H, Manor I, Shiloh R, Aizenberg D, Benjamini Y, Munitz H, et al. High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome. J Clin Psychopharmacol 2002; 22(3): 252−6.

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Text Revision. Washington, DC: American Psychiatric Publishing; 2000.

Guzofski S, Peralta R. Neuroleptic Malignant Syndrome, with Attention to Its Occurrence with Atypical Antipsychotic Me-dication: A Review. Jefferson J Psychiatry 2006; 20(1): 53−62.

Kemperman CJ, van den Hoofdakker RH. Neuroleptic malignant syndrome (NMS): challenge with zuclopenthixol and follow-up: a case report. Eur Neuropsychopharmacol 1990; 1(1): 67−9.

Benzer TI, Tarabar A. Neuroleptic Malignant Syndrome in Emergency Medicine. Medscape 2012. Available from: emedi-cine.medscape.com/article/816018-overview‎ [cited 2012 June 7].

Kennedy PG. Viral encephalitis: causes, diferential diagnosis, and management. J Neurol Neurosurg Psychiatry 2004; 75(90001): 10−5.

Huang TL. Neuroleptic malignant syndrome associated with long-term clozapine treatment: report of a case and results of a clozapine rechallenge. Chang Gung Med J 2001; 24(8): 522−5.

Published
2015/04/23
Section
Case report